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students: an economic evaluation
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Abstract
Background: Too many young people engage in unhealthy behaviours such as eating unhealthily, being physically
inactive, binge drinking and smoking. This study aimed to estimate the short-term and long-term cost-effectiveness
of a theory-based online health behaviour intervention (“U@Uni”) in comparison with control in young people starting
university.
Methods: A costing analysis was conducted to estimate the full cost of U@Uni and the cost of U@Uni roll-out. The
short-term cost-effectiveness of U@Uni was estimated using statistical analysis of 6-month cost and health-related
quality of life data from the U@Uni randomised controlled trial. An economic modelling analysis combined evidence
from the trial with published evidence of the effect of health behaviours on mortality risk and general population data
on health behaviours, to estimate the lifetime cost-effectiveness of U@Uni in terms of incremental cost per QALY. Costs
and effects were discounted at 1.5% per annum. A full probabilistic sensitivity analysis was conducted to account for
uncertainty in model inputs and provide an estimate of the value of information for groups of important parameters.
Results: To implement U@Uni for the randomised controlled trial was estimated to cost £292 per participant, whereas
roll-out to another university was estimated to cost £19.71, both giving a QALY gain of 0.0128 per participant. The
short-term (6-month) analysis suggested that U@Uni would not be cost-effective at a willingness-to-pay threshold of
£20,000 per QALY (incremental cost per QALY gained = £243,926). When a lifetime horizon was adopted the results
suggest that the full implementation of U@Uni is unlikely to be cost-effective, whereas the roll-out of U@Uni to another
university is extremely likely to be cost-effective. The value of information analysis suggests that the most important
drivers of decision uncertainty are uncertainties in the effect of U@Uni on health behaviours.
Conclusions: The study provides the first estimate of the costs and cost-effectiveness of an online health behaviour
intervention targeted at new university students. The results suggest that the roll-out, but not the full implementation,
of U@Uni would be a cost-effective decision for the UK Department of Health, given a lifetime perspective and a
willingness-to pay threshold of £20,000 per QALY.
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Background
Too few young people engage in healthy behaviours such
as eating healthily, being physically active, consuming
alcohol sensibly and not smoking. For example, evidence
from the 2008 Health Survey for England [1] suggested
that only 20% of young people (aged 16–24) eat five por-
tions of fruit and vegetables per day, less than 50% meet
weekly physical activity guidelines, 25% smoke, and 40%
exceed daily recommended alcohol limits. These health
behaviours amongst young people have an effect on health
in terms of risk of illness and disease, mortality risk, and
quality of life [2].
The transition from school to university offers a unique
opportunity to intervene to promote the adoption of
healthy behaviours in young people, as a large number of
people can be targeted easily and at a time when they may
be open to changes to their lifestyle [3]. An online health
promotion intervention (“U@Uni”) has been designed to
use the transition from school to university to promote
healthy behaviours in young people [3]. The intervention
was developed based on three key psychological theories:
self-affirmation [4], the Theory of Planned Behaviour [5],
and implementation intentions [6]. In summary, the inter-
vention provides an online portal for young people to
self-affirm, view multimedia theory-based health messages,
make implementation intentions and access information
about healthy resources (such as exercise facilities and
greengrocers) in their local area. U@Uni is designed to be
accessed by young people in the month before they start
university. The intervention has been compared to a ‘meas-
urement only’ control condition in a randomized con-
trolled trial (RCT) of 1,445 young people beginning their
studies at the University of Sheffield, United Kingdom
(UK). Data were collected from RCT participants at base-
line and at 1-month and 6-month follow-up. Full details of
the U@Uni intervention and the RCT have been published
elsewhere [3,7].
To determine whether an intervention provides good
value for money, an economic evaluation comparing the
costs and benefits of the intervention with those of a rele-
vant control is required. In the UK, the National Institute
for Health and Care Excellence (NICE) is the organization
responsible for evaluating health technologies and produ-
cing clinical and public health guidelines. NICE recom-
mends that public health interventions be evaluated using
quality-adjusted life years (QALYs) as the measure of
benefit [8]. QALYs are a combined measure of length
and quality of life, and are calculated by multiplying
the number of years spent in a particular state of health by a
utility value for that health state, derived from a preference-
based measure of health-related quality of life [9]. This study
aimed to estimate the short-term (6-month time horizon)
and long-term (lifetime time horizon) cost-effectiveness of
the U@Uni online health behaviour intervention in young
people starting university. Given the absence of current best
practice guidance, the intervention was compared solely
against the ‘measurement only’ control condition from the
RCT.
Methods
The economic evaluation was conducted in three
parts: (i) a costing analysis to estimate the cost of
U@Uni, (ii) a within-trial statistical analysis to estimate
the short-term cost-effectiveness of U@Uni using EQ-5D
data [10] collected within the 6-month RCT follow-up
period, and (iii) an economic modelling analysis to esti-
mate the long-term cost-effectiveness of U@Uni. Eco-
nomic modelling was necessary to extrapolate the health
behaviour outcomes from the RCT over the long term
and to link the intermediate health behaviour outcomes
with long-term costs, life years and QALYs. Economic
modelling provides the necessary framework for synthesis
of data from multiple sources in order to estimate long-
term cost-effectiveness. In this study individual-level 6-
month follow-up data from the U@Uni RCT (N = 1,445)
[7] were synthesized with individual-level cross-sectional
data on health behaviours in the general UK population
from the Health Survey for England 2008 (N = 14,925) [1]
and hazard ratios linking all four of the health behaviours
to mortality risk from a published survival analysis (N =
4,886) [11]. The perspective of the study is that of the UK
Department of Health. Ethical approval for the RCT was
obtained from the Department of Psychology Research
Ethics Committee at the University of Sheffield.
Costing analysis
The cost of U@Uni was estimated using a questionnaire
administered to the staff involved in the development
and implementation of the intervention from the Depart-
ment of Psychology and the Department of Computer Sci-
ence at the University of Sheffield. Each member of staff
was asked to estimate the number of hours they had spent
on different aspects of developing and implementing
U@Uni (central estimate and upper and lower bounds
to represent their uncertainty in their central estimates).
Examples of aspects that Department of Psychology mem-
bers of staff were asked to estimate included “developing
health messages” and “development of local elements”
(local elements included information about healthy re-
sources available in the local area e.g. exercise facilities
and greengrocers). Examples of aspects that Depart-
ment of Computer Science members of staff were asked
to estimate included “developing the website version”
and “website monitoring and maintenance”. See section
A of Additional file 1 for further details. The University
of Sheffield’s University Research Management System
was used to estimate the full economic cost of all staff
time using individual staff members’ salaries and working
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hours plus additions for on-costs (i.e., tax, national in-
surance and pensions) and overheads. Non-staff costs
included the cost of questionnaire software and payments
to participants for formative research used to develop the
health messages. Two different per-person costs of U@Uni
were calculated:
First, the within-trial cost of full development and
implementation of the intervention at the University of
Sheffield was estimated:
Full within‐trial cost
¼ Total cost of U@Uni development
Number of individuals in the intervention arm of the U@Uni RCT
Second, the roll-out cost of implementing the interven-
tion at other UK universities was estimated, assuming that
University of Sheffield salaries and overheads are nation-
ally representative: [12]
Roll‐out cost
¼ Cost of developing local elements þ Cost of testing and monitoring the interventionð Þ
Average number of people starting at a UK university in 2012
Means and upper and lower 95% confidence inter-
vals for the mean population-level cost for each of the
two cost scenarios were generated (see section A of
Additional file 1 for further details).
Within-trial cost-effectiveness analysis (short-term
6-month time horizon)
The baseline characteristics of participants in the RCT
are presented in Table 1. The full development and im-
plementation cost of the U@Uni intervention and the
cost of other health care resources consumed during the
6-month follow-up period of the U@Uni RCT were weighed
against the QALYs accrued during this time in a within-trial
cost-effectiveness analysis. The cost of the intervention was
estimated as outlined above. The healthcare resources used
by individuals in each arm of the RCT were estimated using
a questionnaire given to participants at 6-month follow-up
that asked them to report the number of GP visits, hospital
inpatient admissions, hospital outpatient attendances, emer-
gency department attendances and ambulance call-outs they
had needed during the previous 6 months. Unit costs were
attached to each of these resources using NHS Reference
Costs 2011-12 [13] and the Unit Costs of Health and Social
Care 2012 [14] (see section B of Additional file 1 for further
details). The QALYs accrued by participants in each arm of
the RCT were estimated from health-related quality-of-life
data measured using preference-based EQ-5D utility values
[10] collected at baseline, 1-month and 6-month follow-up.
Missing utility data at either follow-up point was imputed
with that individuals’ utility value from the other follow-up
point (a combination of last observation carried forward and
last observation carried backward). QALYs were calculated
using the trapezium rule [15].
Rather than comparing the mean costs and QALYs
from the raw data, regression models were used to con-
trol for differences at baseline between the two RCT arms.
Ordinary least squares regression was used to estimate the
effect of the RCT arm on total RCT costs (intervention
cost + other healthcare costs) and total RCT QALYs.
There were two regression models: One of total costs
(N = 672) and one of total QALYs (N = 643), both with
RCT arm as an index covariate. Age, gender, baseline
fruit and vegetable consumption, baseline alcohol con-
sumption, baseline physical activity and baseline smok-
ing status were included as covariates in both the cost
and QALY regression models. For the regression of QALYs,
baseline utility value was also included as a covariate to
reduce bias [16]. To examine uncertainty, non-parametric
bootstrapping (5,000 replicates) was used to generate a
joint distribution of mean costs and QALYs from the pre-
dicted individual-level costs and QALYs. This distribution
was used to calculate the mean costs and QALYs in each
arm of the trial, the incremental cost-effectiveness ratio
(ICER; incremental cost per QALY), and the probability of
U@Uni being cost-effective within 6 months at different
willingness-to-pay thresholds.
Long-term economic modelling (lifetime time horizon)
The long-term cost-effectiveness of U@Uni was estimated
using an economic model developed to translate changes
in health behaviours into long-term life years and QALYs.
The model structure was informed by a brief review of
existing public health models that incorporated one or
more of the relevant behavioural changes. It was designed
as a population-based individual patient-level simulation
model with annual time cycles simulating transitions
between two Markov states (alive and dead) over time
(see Figure 1). The baseline age, gender, daily portions
of fruit and vegetables consumed, weekly units of alcohol
consumed, weekly minutes of physical activity undertaken
and smoking status (smoker or non-smoker) of simulated
individuals were taken from baseline data collected in the
U@Uni RCT (see Table 1). The same individuals were
simulated under the U@Uni intervention and control
conditions.
Follow-up health behaviours were modelled as a func-
tion of baseline health behaviours and U@Uni interven-
tion effects. The effects of U@Uni on daily portions of
fruit and vegetables, weekly units of alcohol and weekly
minutes of physical activity were modelled using or-
dinary least squares regressions with age, gender and
the corresponding baseline behaviour as covariates
(see section C of Additional file 1). The coefficients
from the regressions are presented in the ‘Intervention
effect regression coefficients’ section of Table 1. Random
samples from the distributions of regression residuals from
each regression model were added to each individual’s
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Table 1 Model input parameters
Parameter Distribution Parameters* Source
Individual characteristics
Age (years) Individual-level data Mean = 18.90 U@Uni RCT
SD = 2.49
Gender Individual-level data 42% Male
58% Female
Fruit and vegetables (portions per day) Individual-level data Mean = 6.52
SD = 4.94
Alcohol (units per week) Individual-level data Mean = 11.51
SD = 18.62
Physical activity (minutes per week) Individual-level data Mean = 163.35
SD = 121.74
Smoking status Individual-level data 12% Smoker
88% Non-smoker
Costs
U@Uni cost (full development) Lognormal Mean ln(cost) = 12.2763 Costing analysis
SD ln(cost) = 0.0513
U@Uni cost (roll-out) Lognormal Mean ln(cost) = 10.3349 Costing analysis
SD ln(cost) = 0.0663
Intervention effect regression coefficients
β0 Fruit and vegetables: constant Multivariate normal
(see section C of Additional file 1
for covariance matrix)
Mean = 3.0095 U@Uni RCT
β1 Fruit and vegetables: baseline behaviour coefficient Mean = 0.2482
β2 Fruit and vegetables: age coefficient Mean = 0.0586
β3 Fruit and vegetables: gender coefficient
(1 =male; 0 = female)
Mean = -0.0252
β4 Fruit and vegetables: intervention coefficient
(i.e. mean effect of U@Uni on portions of fruit and
vegetables per day compared to control)
Mean = -0.1116
ε Fruit and vegetables: residual Normal Mean = -3.18 × 10-09 U@Uni RCT
SD = 4.8973
β0 Alcohol: constant Multivariate normal
(see section C of
Additional file 1
for covariance matrix)
Mean = 18.9219 U@Uni RCT
β1 Alcohol: baseline behaviour coefficient Mean = 0.4834
β2 Alcohol: age coefficient Mean = -0.5772
β3 Alcohol: gender coefficient (1 =male; 0 = female) Mean = -0.4252
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Table 1 Model input parameters (Continued)
β4 Alcohol: intervention coefficient
(i.e. mean effect of U@Uni on units of
alcohol per week compared to control)
Mean = -0.4275
ε Alcohol: residual Normal Mean = 1.85 × 10-08 U@Uni RCT
SD = 19.9055
β0 Physical activity: constant Multivariate normal
(see section C of
Additional file 1
for covariance matrix)
Mean = 161.3326 U@Uni RCT
β1Physical activity: baseline behaviour coefficient Mean = 0.2339
β2 Physical activity: age coefficient Mean = -2.7763
β3 Physical activity: gender coefficient
(1 =male; 0 = female)
Mean = -2.0189
β4 Physical activity: intervention coefficient
(i.e. mean effect of U@Uni on minutes of
physical activity per week compared to control)
Mean = 4.0141
ε Physical activity: individual residual Normal Mean = -1.38 × 10-07 U@Uni RCT
SD = 106.0016
Probability smokers quit smoking (U@Uni) Beta α = 27 U@Uni RCT
β = 33
Probability non-smokers start smoking (U@Uni) Beta α = 14 U@Uni RCT
β = 466
Probability smokers quit smoking (do nothing) Beta α = 19 U@Uni RCT
β = 45
Probability non-smokers start smoking (do nothing) Beta α = 27 U@Uni RCT
β = 462
Lag effects (years until full effect of behaviour change on mortality risk)
Fruit and vegetables lag Lognormal Mean = 2.7438 Expert elicitation
SD = 0.1247
Alcohol lag Gamma α = 1.3541 Expert elicitation
β = 0.6537
Physical activity lag Normal Mean = 5.5000 Expert elicitation
SD = 1.4642
Smoking lag Normal Mean = 5.5000 Expert elicitation
SD = 1.1110
Distribution of individual-level duration of U@Uni behavioural effect (years)**
Mean duration Beta α = 1.8179 Expert elicitation
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Table 1 Model input parameters (Continued)
β = 0.1304
Scale = 4.5000
Standard deviation of duration Beta α = 2.9109 Expert elicitation
β = 0.2691
Scale = 3.3800
Hazard ratios for effect of health behaviours on mortality risk
Fruit and vegetable consumption Lognormal Mean = 0.0953 Kvaavik et al. (2010) [11]
SD = 0.0673
Alcohol consumption Lognormal Mean = 0.1655 Kvaavik et al. (2010) [11]
SD = 0.0840
Physical activity Lognormal Mean = 0.3577 Kvaavik et al. (2010) [11]
SD = 0.0641
Smoking status Lognormal Mean = 0.3577 Kvaavik et al. (2010) [11]
SD = 0.0873
Utility ordinary least squares regression model coefficients
β0 Constant Multivariate normal
(see section F of Additional file 1
for covariance matrix)
Mean = 0.9490 Analysis of Health Survey for
England 2008 [1]β1 Age coefficient Mean = -0.0038
β2 Gender (1 =male; 0 = female) coefficient Mean = 0.0142
β3 Fruit and vegetables (portions per day) coefficient Mean = 0.0207
β4 Alcohol (units per week) coefficient Mean = 0.0016
β5 Smoke (smoker = 1; non-smoker = 2) coefficient Mean = -0.0541
β6 Physical activity (minutes per week) coefficient Mean = 0.0002
β7 Age
2 Mean = -4.31 × 10-06
β8 Fruit and vegetables2 Mean = -0.0033
β9 Fruit and vegetables3 Mean = 0.0001
β10 Alcohol2 Mean = -2.77 × 10-05
β11 Alcohol3 Mean = 6.45 × 10-08
β12 Physical activity2 Mean = -2.59 × 10-07
β13 Physical activity3 Mean = 4.88 × 10-11
β14 Age*Fruit and vegetables β0 interaction Mean = 4.94 × 10-05
β15 Age*Alcohol interaction Mean = 1.61 × 10
-05
β16 Age*Physical activity Mean = 2.47 × 10-06
*SD standard deviation.
**The sampled mean and standard deviation from the beta distributions are then converted to log (mean) and log (standard deviation) and used as parameters for the lognormal distribution for individual-level
durations of response.
Kruger
et
al.BM
C
Public
H
ealth
2014,14:1011
Page
6
of
16
http://w
w
w
.biom
edcentral.com
/1471-2458/14/1011
simulated follow-up behaviours to represent heterogeneity
in the behavioural response to U@Uni, so that the simu-
lated value for an individuals’ follow-up behaviour was cal-
culated as:
BHT1 ¼ β0 þ β1BHT0 þ β2age þ β3gender
þ β4intervention þ ε
ð1Þ
Where:
BHT1 = behaviour at 12 months
BHT0 = behaviour at baseline
age = age in years
gender = 1 if male and = 0 if female
intervention = 1 if received U@Uni and = 0 if received
control
β0 - β4 = coefficients as per Table 1
ε = randomly sampled individual residual from
distributions given in Table 1
The effects of U@Uni on smoking were modelled as a
probability of quitting smoking for baseline smokers and
a probability of starting smoking for non-smokers (see
Table 1).
The trajectories of fruit and vegetable consumption, al-
cohol consumption and physical activity over time were
modelled by placing each individual on an age-specific
percentile rank from general population data collected as
part of the Health Survey for England 2008 [1] and then
keeping individuals on the same percentile throughout
their lifetime under the control condition. Under the
intervention condition individuals were kept on the
same percentile rank for the three continuous behav-
iours until the duration of treatment effect was reached,
at which point they reverted to the percentile rank they
would have been on under the control condition. A
probability distribution for the duration of treatment
effect was elicited from psychological experts (see
section D of Additional file 1) and each simulated in-
dividual had a different randomly sampled duration of
treatment effect. Under the intervention condition the be-
havioural effect of U@Uni was modelled with a linear
decay over the period of treatment effect. Smoking status
was modelled as constant over an individuals’ lifetime
under the control condition. Under the intervention con-
dition smoking status was modelled as constant until the
duration of treatment effect was reached, at which point
smoking status reverted to what it would have been under
the control condition.
The underlying age- and gender-specific annual prob-
abilities of dying were taken from UK life tables [17] with
the probability of dying aged 100 years or over set to 1.
The annual probabilities of dying were adjusted for
individual-level health behaviours using hazard ratios
calculated using linear and logarithmic continuous risk
functions developed from hazard ratios reported in a
published survival analysis [11] weighted by health be-
haviours from the Health Survey for England 2008 [1]
(see section E of Additional file 1 for further details).
The distributions used to represent the source hazard
ratios for each health behaviour are presented in the
‘Hazard ratios for effect of health behaviours on mor-
tality risk’ section of Table 1. The hazard ratios for each
simulated individual were modelled as a function of their
health behaviours, e.g., a person drinking more alcohol
would have a higher hazard ratio than an individual drink-
ing less alcohol and their adjusted mortality risk would
therefore also be higher.
There was assumed to be a time lag to the full effect
of behaviours on mortality risk. The lags for each of the
four health behaviours were elicited from epidemio-
logical and economic modelling experts (see section D
of Additional file 1) and were applied so that the full
hazard ratio effect was applied after the simulated lag
(with reduced hazard ratio effects applied in the preceding
time cycles).
The annual probabilities of dying were used to estimate
the number of life years each individual accrued over their
lifetime by multiplying the number of life years accrued in
the previous year by the annual probability of dying in the
current year.
An ordinary least squares regression of Health Survey
for England 2008 data [1] was used to construct a regres-
sion equation to predict EQ-5D utilities from fruit and
vegetable consumption, alcohol consumption, smoking
status, physical activity level, age and gender (see section F
Figure 1 The U@Uni long-term cost-effectiveness model - a two states Markov model. p(dead|alive) = probability of dying if alive = a
function of age, gender, fruit and vegetable consumption, alcohol consumption, physical activity and smoking status. p(alive|alive) = probability of
staying alive if alive = 1 - p(dead|alive). p(dead|dead) = probability of staying dead if dead = 1.
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of Additional file 1 for further details). The coefficients
from the regression are presented in the ‘Utility ordinary
least squares regression model coefficients’ section of
Table 1, and the equation to simulate an individuals’
utility value in any given year was:
U ¼ β0 þ β1 ageð Þ þ β2 genderð Þ þ β3 fvð Þ
þ β4 alcð Þ þ β5 smð Þ þ β6 pað Þ
þβ7 age2ð Þ þ β8 fv2
  þ β9 fv3
 
þ β10 alc2
  þ β11 alc3
  þ β12 pa2ð Þ
þ β13 pa3ð Þ þ β14 agefvð Þ þ β15 agealcð Þ
þ β16 agepað Þ
ð2Þ
Where:
U = EQ-5D utility score
age = Age in years
gender = 1 if male and = 0 if female
fv = portions of fruit and vegetables consumed per day
alc = units of alcohol consumed per week
sm = 1 if smoker and = 0 if non-smoker
pa = minutes of physical activity per week
β0 - β16 = coefficients as per Table 1
The EQ-5D utility regression equation was used to
weight the life years accrued by each simulated person
in each year (based on their health behaviours in that
year) to generate QALYs.
Intervention costs were based on the costing analysis
described above and as they occurred in the first year
they were not discounted. No other costs were included
in the analysis; this was considered to be a conservative
structural assumption as improvements in health behav-
iours as a result of U@Uni could result in reduced mor-
bidity and therefore reduced healthcare costs.
The model was fully probabilistic with each input param-
eter represented by a probability distribution to characterize
uncertainty in the parameter values. The parameter uncer-
tainty was propagated through the model to generate a
distribution of lifetime costs and QALYs for the control
and U@Uni conditions. Full details of the model parame-
ters are given in Table 1. The economic model used a num-
ber of assumptions aside from those described above and
in Table 1; these are presented in Table 2.
Economic analysis
The model was used to evaluate the cost-effectiveness of
the full development and implementation of U@Uni as
per the process at the University of Sheffield and the
cost-effectiveness of rolling out U@Uni to other univer-
sities. Life years and QALYs were discounted annually
at 1.5% as recommended for public health economic
Table 2 Model assumptions
Assumption Implication for modelling
6-month behaviours from the trial are assumed to represent year 1
behaviours in the model.
May over-estimate the duration of U@Uni behavioural treatment effects
by 6 months.
Health Survey for England complete case data represents behavioural
patterns in the general population that is represented in the ONS Life
Tables.
Complete cases from Health Survey for England may be atypical and not
representative of the general population in some way (unclear effect on
results)
Probability of death aged >100 years = 1 May under-estimate life expectancy increases as a result of U@Uni.
Assumes health behaviours from Health Survey for England when aged
over 90 are equal to those when aged 90
Health behaviours of people aged over 90 may be different from those of
people aged 90 in some way (unclear effect on results).
Assumes relationship between alcohol and mortality risk is linear and
between physical activity or fruit and vegetables and mortality risk is
logarithmic (to avoid negative values for hazard ratios)
The shape of the true relationship between the health behaviours and
mortality risk may have a different functional form (unclear effect on
results).
Hazard ratio for 0 portions fruit and vegetables = 1.6 May under- or over-estimate the increased mortality risk associated with
eating no fruit and vegetables (unclear effect on results).
Hazard ratio for 0 minutes of physical activity = 1.6 May under- or over-estimate the increased mortality risk associated with
doing no physical activity (unclear effect on results).
Except for due to the effect of U@Uni an individuals’ fruit and vegetable
consumption, physical activity, and alcohol consumption measured
6-months after university are assumed to stay on the same age-specific
percentile rank from the general population throughout their lifetime
Individuals’ health behaviours could be expected to vary more than this
over a lifetime (unclear effect on results).
Except for due to the effect of U@Uni an individuals’ smoking status
measured 6-months after university is assumed to stay fixed throughout
their lifetime
Individuals’ smoking status could be expected to vary more than this
over a lifetime (unclear effect on results).
Health behaviour change decays linearly up to the year of the maximum
length of the treatment effect
Behaviour change may decay non-linearly (unclear effect on results).
Hazard ratios for the effect of health behaviours on mortality risk are age
independent
The relative effect of health behaviours on mortality risk may vary with
age (unclear effect on results).
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evaluations by NICE [8]. In each scenario the lifetime
costs and QALYs of U@Uni were compared to those of
the control condition. In addition, a threshold analysis
was conducted to identify the threshold price per per-
son that would be required for U@Uni to be considered
cost-effective at the NICE willingness-to-pay threshold
of £20,000 per QALY [8].
Uncertainty
A full probabilistic sensitivity analysis was conducted to
estimate the probability of U@Uni being cost-effective at
different willingness-to-pay thresholds. Monte Carlo prob-
abilistic sensitivity analysis was conducted by randomly
sampling a value for each input parameter, running the
model, and repeating this process 5,000 times. For each
run 1,000 individuals were simulated. The probabilistic
sensitivity analysis was used to generate a joint distribu-
tion of incremental costs and QALYs, jack-knife confi-
dence intervals for the ICER, and a cost-effectiveness
acceptability curve [18]. The expected value of collect-
ing further data to populate model parameters was esti-
mated using expected value of perfect information
analysis [19,20] with a focus on identifying which pa-
rameters should be targeted in any further research
[21]. Three structural sensitivity analyses were conducted
to explore the sensitivity of the model results. First, a dif-
ferent discount rate for costs and QALYs (3.5% per annum
as recommended by the NICE methods guide for health
technology appraisal [22]); second, the use of a utility re-
gression function that used only age and gender as predic-
tors and therefore did not account for the effects of health
behaviours on quality of life [23] and third, varying the
duration of intervention effect from 4.5 years to between
one and ten years.
Results
Costing analysis results
The results of the costing analysis suggested that U@Uni
would cost £208,500 (95% confidence interval £194,723
to £238,611) to fully develop and implement as per the
University of Sheffield U@Uni RCT. This included £119,179
in staff costs, £2,355 in non-staff costs (for questionnaire
software and payments to participants in formative re-
search), and £86,966 in overheads (including estates, in-
frastructure and indirect costs). Based on the number
of participants in the intervention arm of the U@Uni
RCT (N = 736) the per-person cost to fully develop and
implement U@Uni was estimated to be £283.29. It was
estimated that rolling out U@Uni to another university
would cost an average of £29,988 (95% confidence
interval £27,054 to £35,081). This included £13,146 in
staff costs, £300 in non-staff costs for questionnaire
software, and £16,542 in overheads. Based on the aver-
age number of people starting at a UK university in 2012
(N = 1,565) [12] the per-person cost to roll out U@Uni to
another university was estimated to be £19.16 (the
per-person cost to roll out to all UK universities was
very similar = £20.64).
Within-trial cost-effectiveness results (short-term 6-month
time horizon)
The results of the within-trial cost-effectiveness analysis
suggest that over a 6-month time horizon the U@Uni
intervention would cost an additional £326 per participant
and generate an additional 0.0013 QALYs per person com-
pared to the control condition. The total mean costs were
£148.69 in the control arm and £474.96 in the intervention
arm. The additional costs in the intervention arm were
primarily a result of the intervention cost (£283.29) and
slightly more inpatient admissions in the U@Uni arm
of the trial than the control arm (an average of 0.06
compared to 0.04 admissions per person over the 6-
month RCT follow-up period). The incremental costs
and QALYs resulted in an ICER for U@Uni of £243,926
(95% confidence interval £234,805 to £252,873) per add-
itional QALY gained. This is a much higher cost per
QALY than bodies such as NICE would be prepared to
accept and suggests that in the short term, the U@Uni
intervention would not be considered cost-effective. In-
deed, the uncertainty analysis found that U@Uni has a 0%
probability of being considered cost-effective at the com-
monly used willingness-to-pay threshold of £20,000 per
QALY (see Figure 2).
Long-term economic modelling results (lifetime time horizon)
Detailed results of the long-term economic modelling
are presented in Table 3. The analysis estimates that the
changes in health behaviours resulting from U@Uni would
produce a small increase in mean survival of approximately
0.0008 years (0.29 days) per person (discounted at 1.5% per
annum) compared to the control condition. The estimated
gains in health-related quality of life are appreciably larger
than the survival benefits, and the modelling suggests that
U@Uni would generate an additional 0.0128 discounted
QALYs per person compared to the control condition. A
reduction in smoking prevalence due to the U@Uni inter-
vention was found to be a statistically significant result in
the trial. The model suggests that an individual’s propensity
to smoke is 6.3% lower in the intervention arm compared
with the control arm.
For the full development and implementation of U@Uni
as per the University Sheffield RCT, it is estimated that
the ICER would be £22,844 per additional QALY gained
(jack-knife 95% confidence interval based on 5,000 model
runs £22,501 to £23,185) versus control. At the £20,000
per QALY threshold, the full development and implemen-
tation of U@Uni would have a 38% probability of being
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cost-effective compared to the control condition (see
Figure 3A and C). The cost per smoker avoided is £55,882.
For the roll-out of U@Uni to other universities, the cost
per additional QALY gained is estimated to be £1,545
(jack-knife 95% confidence interval £1,521 to £1,568) ver-
sus control. Clearly, this is substantially better than the
£20,000 per QALY threshold and would be likely to be
considered very cost-effective. The uncertainty analysis es-
timates a 97% probability that U@Uni roll-out would be
cost-effective at the £20,000 per QALY threshold (see
Figure 3B and D). The cost per smoker avoided is £3,778.
The cost threshold analysis suggested that the U@Uni
intervention could be priced at anything up to £255
per participant in order to be cost-effective at a £20,000
per QALY threshold (see Table 3). At a price of £160 per
person U@Uni would have a 75% probability of being
cost-effective and at a price of £85 per person U@Uni
would have a 90% probability of being cost-effective. If
U@Uni were provided at zero cost there would be a 98%
probability that it would be cost-effective (the remaining
2% represents the chance that U@Uni could generate
fewer QALYs than the control condition).
Sensitivity analyses suggest that the results are not sensi-
tive to changes in the discount rate used (ICER = £24,324
for full development and implementation and ICER =
£1,645 for roll-out) but are very sensitive to the use of util-
ity weights that did not account for the effects of health
behaviours on quality of life (ICER = £664,205 for full de-
velopment and implementation and ICER = £44,916 for
roll-out). If the potential quality of life benefits of improv-
ing health behaviours are not included in the modelling,
then the results suggest that U@Uni would not be consid-
ered cost-effective on the basis of estimated survival bene-
fits alone, even at the cheaper roll-out cost. This reiterates
the earlier finding that it is the estimated health-related
quality of life benefits related to the behaviour changes
within the model that are the important drivers when con-
sidering cost-effectiveness.
The results are very sensitive to modification of the
duration of intervention effect (see Figure 3E and F). The
roll-out of U@Uni would have a 92% probability of being
cost-effective even if the duration of effect is minimal (one
year; ICER = £4,261), whereas the full development of the
intervention only becomes likely to be cost-effective if the
duration of effect is more than five years. Given the lack of
published data on the long-term effect of internet-based
interventions, this is an area that would benefit from fur-
ther research.
Value of information analysis
The results suggest that the overall value of information
(as quantified by the overall expected value of perfect in-
formation) for the full development and implementation
of U@Uni was £39 per person and that the parameters
with the highest expected value of information were the
coefficients for the effect of U@Uni on health behaviours.
Using a target population equal to the number of people
starting university in the UK in 2012 (N = 464,891) [12],
the overall population value of information was £18.3
million in the first year of the U@Uni intervention. The
expected value of information suggests that the cost of
the decision uncertainty is £39 per person and therefore
society should not be willing to pay more than £39 per
Figure 2 Within-trial 6-month cost-effectiveness planes and
cost-effectiveness acceptability curves for U@Uni compared to
do nothing. Presents the individual-level cost-effectiveness plane
and cost-effectiveness acceptability curve resulting from the 5,000
bootstrap replicates in the within-trial cost-effectiveness analysis.
A) Cost-effectiveness plane showing the per-person incremental
6-month within-trial costs and incremental 6-month within-trial
QALYs for full development and implementation of U@Uni compared
to do nothing. B) Cost-effectiveness acceptability curve showing the
probability (out of 5,000 bootstrap replicates) of full development and
implementation of U@Uni being cost-effective compared to do
nothing at different willingness-to-pay thresholds.
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person to collect further evidence to resolve the uncer-
tainty in the model outputs. A further interpretation is
that the expected value of perfect information is the
“opportunity loss” of making the decision about whether
to fund U@Uni now rather than waiting for additional evi-
dence to be collected to reduce the decision uncertainty.
The two most important parameters driving the decision
uncertainty in the model are, firstly, the effectiveness of
U@Uni on physical activity, and secondly, the probability
that non-smokers will start smoking in the control condi-
tion (see Figure 4A).
The results suggest that the overall expected value of
perfect information for the roll-out of U@Uni was £1.71
per person and that the most important parameter driving
the decision uncertainty in the model was the coefficient
for the effect of U@Uni on physical activity (see Figure 4B).
Using the same target population as above, the overall
population value of information was calculated as
£794,964 in the first year of roll-out.
Discussion
Data from a RCT of a theory-based online health behav-
iour intervention for new university students (“U@Uni”)
were used to estimate the cost of the intervention and
its short-term cost-effectiveness. The RCT data were also
combined with evidence from the literature and popula-
tion level datasets in an economic modelling analysis to
estimate the long-term cost-effectiveness of the interven-
tion. The costing results suggested that the intervention
would cost £208,500 (£283 per student) to fully develop
Table 3 The long-term cost-effectiveness of U@Uni results (all results are per person)
Do
nothing
U@Uni Incremental*
Scenario 1: Full development and implementation of U@Uni
Discounted life years 39.5088 39.5096 0.0008
Discounted QALYs 33.2426 33.2553 0.0128
Discounted costs £0.00 £291.53 £291.53
ICER - - £22,844
Net monetary benefit (NMB)** at threshold of £20,000 per QALY - - -£36.30
Probability U@Uni is cost-effective at willingness-to-pay threshold of
£20,000 per QALY
- - 38.18%
Cost per smoker avoided with U@Uni - - £55,882
Scenario 2: Roll-out of U@Uni
Discounted life years 39.5088 39.5096 0.0008
Discounted QALYs 33.2426 33.2553 0.0128
Discounted costs £0.00 £19.71 £19.71
ICER - - £1,545
Net monetary benefit (NMB)** at threshold of £20,000 per QALY - - £236
Probability U@Uni is cost-effective at willingness-to-pay threshold of
£20,000 per QALY
- - 96.54%
Cost per smoker avoided with U@Uni - - £3,778
Threshold cost analysis
U@Uni
price
ICER Probability U@Uni is cost-effective at £20 K
threshold
£0 £0 97.64%
£5 £392 97.56%
£10 £784 97.32%
£25 £1,959 96.26%
£50 £3,918 94.34%
£100 £7,836 87.36%
£150 £11,754 77.54%
£200 £15,672 64.38%
£255 £19,981 48.24%
*Any apparent discrepancies are due to rounding.
**Net monetary benefit = incremental QALYs x willingness-to-pay threshold – incremental costs.
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Figure 3 (See legend on next page.)
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and implement and £29,988 (£19 per student) to roll out
to another university. The economic analysis results sug-
gested that U@Uni would not be cost-effective over a 6-
month time horizon; this result is not unexpected given
that the effects of the intervention on QALYs are likely to
be longer term. The lifetime horizon economic analysis sug-
gested that that the full development and implementation of
U@Uni had a 38% probability of being cost-effective over a
lifetime and that roll-out of U@Uni (i.e., excluding sunk
costs) had a 97% probability of being cost-effective over a
lifetime. These results were more sensitive to the compo-
nent of the model estimating the relationship between
health behaviours and changes in health-related quality of
life than the components relating to mortality risk.
(See figure on previous page.)
Figure 3 Long-term cost-effectiveness planes and cost-effectiveness acceptability curves for U@Uni compared to do nothing.
PSA = Probabilistic sensitivity analysis. A) Cost-effectiveness plane showing the per-person incremental discounted lifetime costs and incremental
discounted lifetime QALYs for full development and implementation of U@Uni compared to do nothing. B) Cost-effectiveness plane showing the
per-person incremental discounted lifetime costs and incremental discounted lifetime QALYs for roll-out of U@Uni compared to do nothing.
C) Cost-effectiveness acceptability curve showing the probability (out of 5,000 PSA runs) of full development and implementation of U@Uni being
cost-effective compared to do nothing at different willingness-to-pay thresholds. D) Cost-effectiveness acceptability curve showing the probability
(out of 5,000 PSA runs) of U@Uni roll-out being cost-effective compared to do nothing at different willingness-to-pay thresholds. E) A line chart
showing the ICER and the probability (out of 5,000 PSA runs) of full development and implementation of U@Uni being cost-effective compared
to do nothing at different intervention effect durations. F) A line chart showing the ICER and the probability (out of 5,000 PSA runs) of U@Uni
roll-out being cost-effective compared to do nothing at different intervention effect durations.
Figure 4 Expected value of overall and parameter perfect information per person. Expected value of overall perfect information per person
and expected value of perfect information for individual parameters per person at a willingness-to-pay threshold of £20,000 per QALY. A) Full
development and implementation of U@Uni. B) Roll-out of U@Uni to another university.
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The long-term modelling indicates that a QALY gain
of 0.0128 per person is obtained from the intervention.
This is a relatively small number and it might be expected
that the cost-effectiveness of the intervention would be
highly sensitive to costs. However, the value of informa-
tion analysis did not find the cost data to be an important
driver of decision uncertainty in the model (Figure 4).
Furthermore, the cost-threshold analysis indicates that
the U@Uni roll-out could be priced at anything up to
£255 per person and still be likely to be cost-effective.
Given that the actual roll-out costs are under £20 per
person, prices would therefore have to increase by over
10 fold to approach the threshold. This indicates that
in fact the ICER is not particularly sensitive to costs,
despite the small QALY value.
The cost-effectiveness of roll-out of U@Uni compares
favourably with other public health and health behaviour
interventions and the full development and implementa-
tion of U@Uni is not excessively high compared to pre-
viously published evidence on the cost-effectiveness of
similar behavioural interventions. In 2007, Gordon et al.
conducted a review of cost-effectiveness studies of face-
to-face behavioural interventions for smoking, physical
activity, diet and alcohol [24]. The review found that ICERs
for most face-to-face multiple behaviour interventions
ranged from cost saving to €24,691 (2006 Euros; approxi-
mately £24,187 at 2011/2012 prices) per QALY. The
ICER for full development and implementation of U@Uni
(£22,844) falls towards the upper end of this range and the
ICER for roll-out of U@Uni falls towards the lower end of
the range, suggesting that an online multiple behaviour
intervention can generate a similar ratio of costs to
benefits as that generated by face-to-face interven-
tions. In 2009, Tate et al. conducted a review of the
cost-effectiveness of internet interventions [25]. They
found a lack of published economic evidence relating
to internet-based interventions, and none of the stud-
ies they identified were targeted at improving general
population health behaviours. Although this has improved
somewhat in recent years, there remains a paucity of
published economic evaluations of internet based inter-
ventions to improve multiple health behaviours. To our
knowledge, the current study is the first to analyse the
cost-effectiveness of such an intervention in university stu-
dents, and so should be a useful addition to the growing
body of literature on internet-based interventions.
The current study provides estimates of both the sunk
costs and roll-out costs of an internet intervention tar-
geted at multiple health behaviour change. In 2012, Owen
et al. published a review of the cost-effectiveness of public
health interventions in the UK based on evidence from
evaluations conducted by NICE [26]. The review found
that the majority (71%) of ICERs for public health inter-
ventions were below £20,000 per QALY, as was the case
for the roll-out cost of U@Uni in the current study. Of the
200 cost-effectiveness estimates reviewed by Owen et al.,
seven cost between £20,000 and £30,000 per QALY as was
the case for the full development and implementation of
U@Uni in the current study.
The methods used in the current study have some lim-
itations. First, the economic modelling took a broad ap-
proach, using risk of mortality from an epidemiological
study by Kvaavik et al. [11] to translate behaviour change
into long-term QALYs. An alternative approach would
be to incorporate the effects of health behaviours on risk
of individual diseases such as diabetes, coronary heart
disease and cancers, and model mortality and quality of
life as a function of these diseases rather than directly as
a function of health behaviours. This additional level of
detail could have generated different estimates of the
cost-effectiveness of U@Uni. Second, because morbidity
was not explicitly modelled, the economic analysis only
included the cost of the U@Uni intervention and did not
take account of ongoing long-term costs of morbidity, e.g.,
the cost to the NHS of caring for diabetes, heart attacks
and cancers. The authors consider this a conservative
structural assumption because improvements in health
behaviours as a result of U@Uni would be expected to
produce savings in health care costs over the longer-
term. A third limitation is that the economic model only
partially accounts for the correlation between health be-
haviours at the individual level. Correlations at baseline
are incorporated from the U@Uni RCT data; however, in
the long-term extrapolation, the model assumes individ-
uals maintained their behaviours exactly as per their per-
centile ranks in the Health Survey for England 2008 general
population data [1], and correlations in the change in
behaviours over six months are not incorporated as
each health behaviour change is simulated independ-
ently. A fourth limitation is the lack of published data
on duration of intervention effect, meaning that expert
elicitation had to be sought to populate this parameter.
The sensitivity analysis results indicate that roll-out of
the intervention is still highly likely to be cost-effective
even if the effect endures only one year. However, cost-
effectiveness of the full design and implementation of
the intervention is highly sensitive to duration of effect.
A final limitation is that the cost analysis was primarily
based on retrospectively recalled self-report of the number
of hours spent developing and implementing U@Uni,
whereas a prospective micro-costing study may have
provided a more accurate estimate of the cost of the
intervention.
The expected value of information analysis suggested
that the effect of U@Uni on fruit and vegetable consump-
tion, physical activity, alcohol consumption and smoking
were the model parameters most worth investing in as
part of any future research. Reducing the uncertainty in
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these parameters could substantially reduce the decision
uncertainty about whether to fund U@Uni. The U@Uni
RCT included some methodological challenges [7], and
conducting an additional RCT to overcome these chal-
lenges and better estimate the effect of U@Uni on health
behaviours could reduce the model and decision uncer-
tainty. For the decision about whether to roll out U@Uni
to other universities, the value of information analysis sug-
gested that provided the cost of obtaining evidence from
an additional RCT was well below the estimated £794,964
threshold then the research would be considered worth-
while. Other further research could focus on taking a
much more detailed and expanded economic modelling
approach, e.g., explicitly simulating significant morbid-
ities such as diabetes, heart disease and cancers, and
using alternative methods for modelling the trajectories
of behaviours over time and the interactions between
health behaviours. Finally, the use of the model frame-
work for evaluation of other interventions targeted at
single or multiple health behaviours could be explored.
If population characteristics, the cost of the interven-
tion, evidence of the effect of the intervention on health
behaviour(s), and assumptions regarding the duration
of effect were available the model could be very easily
adapted in this way.
In the UK, NICE have the remit of evaluating health
technologies and making recommendations to the De-
partment of Health about whether they should be funded
or not. Based on the economic analysis in this study the im-
plication is that, given a NICE willingness-to-pay threshold
of £20,000 per QALY [8], the implementation of U@Uni
could be recommended as cost-effective provided the roll-
out costs were low enough per participant (i.e., more of the
order of the £19 per participant estimated here and not as
high as the total up-front costs of £283 per participant
for the full development of U@Uni at the University of
Sheffield). It has been assumed that the health behaviour
effects observed in the U@Uni RCT can be generalised to
other universities across the UK. It is unclear at this stage
whether the results can be generalised internationally or
to subgroups of the general population other than new
university students, but any online health behaviour inter-
vention that could generate similar changes in health be-
haviour for similar costs could potentially be expected to
have a similar level of cost-effectiveness.
Conclusions
This study provides the first estimate of the full imple-
mentation (£208,500) and roll-out (£29,988) costs of an
online intervention targeting multiple health behaviours
in new university students. The study is also the first to
explore the cost-effectiveness of an online multiple health
behaviour intervention, providing estimates of both the
short-term (£243,926) and long-term (£22,844 for full
implementation and £1,545 for roll-out) cost per QALY
of U@Uni. The results suggest that based upon the as-
sumptions of the long-term modelling, the roll-out of
U@Uni to other universities would most likely be a cost-
effective option for the UK Department of Health, whereas
the full implementation would not. Uncertainty analysis
suggests that further research (e.g., via a second RCT) that
could reduce uncertainty in the effectiveness of U@Uni on
health behaviours, particularly around changes in physical
activity and duration of intervention effect, would be po-
tentially valuable to decision makers. The new economic
modelling framework developed for this analysis enables
estimation of the effects of changes in fruit and vegetable
consumption, physical activity, alcohol consumption and
smoking into long-term costs and QALYs, and as such
could be used to evaluate a broad range of public health
interventions.
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